Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: cherry grove who wrote (2571)	10/30/1997 11:00:00 AM
From: Randy Schmid	Read Replies (2) \| Respond to of 6136

Looking like there's a general flight to safety - blue chips and bonds? - and away from so called speculative biotech stocks. I'm beginning to wonder if the market and stock will stay decoupled from the company for a while. With investors antsy about the overall world economy, will have to rethink my strategy - although calls and spreads would seem sensible, they're not long term. May perhaps roll down into a deeper in the money spread, knuckle down and ride 'er out. Currently own options expiring in February - after earnings, and in May. Concerned that we may see even more "buying opportunities". Regards, Randy